1. Home
  2. MEG vs GHRS Comparison

MEG vs GHRS Comparison

Compare MEG & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Montrose Environmental Group Inc.

MEG

Montrose Environmental Group Inc.

HOLD

Current Price

$22.36

Market Cap

930.8M

ML Signal

HOLD

Logo GH Research PLC

GHRS

GH Research PLC

HOLD

Current Price

$14.87

Market Cap

808.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEG
GHRS
Founded
2012
2018
Country
United States
Ireland
Employees
3500
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
930.8M
808.2M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
MEG
GHRS
Price
$22.36
$14.87
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$35.25
$41.38
AVG Volume (30 Days)
302.7K
195.9K
Earning Date
05-06-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
93.69
N/A
EPS
N/A
N/A
Revenue
$830,538,000.00
N/A
Revenue This Year
$5.46
N/A
Revenue Next Year
$7.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
19.26
N/A
52 Week Low
$10.51
$7.98
52 Week High
$32.00
$19.51

Technical Indicators

Market Signals
Indicator
MEG
GHRS
Relative Strength Index (RSI) 43.44 52.59
Support Level $21.11 $12.27
Resistance Level $23.78 $16.29
Average True Range (ATR) 1.08 0.88
MACD -0.21 -0.01
Stochastic Oscillator 28.41 69.30

Price Performance

Historical Comparison
MEG
GHRS

About MEG Montrose Environmental Group Inc.

Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits and permits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, and soil remediation. The company derives maximum revenue from United States.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: